Catalyst Wire Dossier Catalyst Wire Dossier

CLE-400

· Clexio Biosciences Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLE-400, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica [Phase 2]

See pricing